Biotechnology movers and shakers on the move. Read new hires, promotions of executives, and more.
Dr Sheelagh Frame has over 25 years’ experience in drug discovery and development, having gained significant expertise on key drug targets in her previous roles as Program Manager and Translational Research Team Manager at Cyclacel Limited, primarily in oncology, but also spanning inflammation, diabetes, and rare diseases
"Justin Bingham brings highly relevant experience to Nabsys, both as a consumer of whole-genome technology and data and as a builder of commercial life sciences organizations," said Barrett Bready, MD, Nabsys Founder and CEO.
Dr Robert Dillman will share findings from trials of AIVITA's personalized vaccine platform for cancer and COVID-19, highlighting the feasibility of the approach, lack of significant toxicity, and observed benefits that support the potential of the company's strategy for personalized dendritic cell therapies.
Shasqi Scientific Advisor Carolyn Bertozzi Awarded Nobel Prize for the Development of Click Chemistry
Note Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in Chemistry, alongside Morten Meldal, Ph.D. (University of Copenhagen, Denmark), and Nobel Laureate K. Barry Sharpless, Ph.D. (Scripps Research, La Jolla, CA, USA), for the development of click chemistry and bioorthogonal chemistry.
Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.
As Executive Chairman, Robert Bitterman will assume the duties of principal executive officer and principal financial officer and will lead all aspects of the Company's operations.